20070211
 In Brief   The Wall Street Journal,  Feb 12, 2007  French drug maker Sanofi-Aventis SA lost a U.S. court case against two generic-drug makers that have been attempting to sell less- expensive versions of Lovenox. Though the patent protecting Lovenox doesn't expire until 2012, Amphastar Pharmaceuticals Inc., of the U.S., and Israel's Teva Pharmaceutical Industries Ltd. have been planning to launch generic copies of the blood thinner in the U.S.   
